- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02139137
Evaluating a Novel Working Memory Training Program to Decrease Symptoms of PTSD
October 4, 2017 updated by: Rick Gulizia
The study is designed to evaluate the effect of a novel computer training program on PTSD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Post-traumatic stress Disorder (PTSD) is a chronic and debilitating disorder that affects millions of people each year (Kessler et al., 2005).
Although effective psychosocial and pharmacological treatments exist for this disorder, as many as 50 percent of individuals still experience symptoms after treatment (Schottenbaeur et al., 2008).
Empirical literature suggests that cognitive deficits may play a role in maintaining symptoms in individuals with PTSD through a variety of mechanisms, including decreased cognitive control over intrusive thoughts (Verwoerd et al., in press) and dysregulation in neural circuitry linking prefrontal cognitive control functions and amygdala activity (McNally, 2007).
The goals of the proposed research are to improve the candidate's understanding of cognitive mechanisms of PTSD symptoms while building skills in conducting treatment research.
The application aims to test a novel methodology for approaching PTSD treatment based on modification of underlying cognitive mechanisms of the disorder.
To this end, 50 participants with PTSD will be randomly assigned to an 8-session executive control training condition designed to improve working memory functioning or a control condition.
The aims of this study are 1) To test the effect of a working memory training program on working memory performance and 2) To examine the effects of this program on PTSD symptoms.
The research plan is complemented by a set of training goals for the candidate to achieve over the proposed award period.
These include 1) training in the use of fMRI and neuropsychological assessment 2) additional coursework and seminars in cognitive science and biostatistics for use in future work, 3) experience with teaching in the undergraduate and graduate setting and presenting original work for publication in preparation for a career in academic research.
Taken together, the research and training components of this grant application will facilitate the candidate's long-term goal of conducting treatment outcome and basic mechanism research in PTSD.
Moreover, as per the strategic plan outlined by NIMH, this application is designed develop an innovative intervention based on prior clinical research and knowledge of cognitive and neurobiological features of the disorder, and will advance knowledge of mechanisms of fear learning.
It is designed to target core cognitive features of the disorder in an effort to reduce symptoms.
PUBLIC HEALTH RELEVANCE: Post-traumatic stress disorder impacts millions of Americans, and is associated with significant personal distress as well as societal cost.
The current application is designed to examine the effect of a novel working memory training program on PTSD symptoms.
This approach is promising in that it may be a cost- effective and accessible method for decreasing symptoms associate with this disorder.
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female
- Age 18-65
- Primary DSM-IV diagnosis of PTSD secondary to sexual trauma
Exclusion Criteria:
- Current trauma or PTSD-focused psychosocial treatment
- Active suicidality, evidence of substance dependence in the past 6 months
- Evidence of current or past schizophrenia
- Bipolar disorder
- Organic mental disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High Interference Control Condition
Computerized training program requiring participants to repeatedly practice controlling interference on a cognitive task
|
Cognitive training using working memory span task
|
Active Comparator: Low Interference Control Condition
Computerized training program requiring participants to minimally practice controlling interference on a cognitive task
|
Sham training condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Clinician Administered PTSD Scale; Re-experiencing
Time Frame: Baseline, Week 4
|
Model estimations of the means and standard deviation of posttreatment score at the mean level of baseline severity reported below. Scale range: 0-40, higher values indicate greater symptom severity |
Baseline, Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinician Administered PTSD Scale Total Score - Responder Status
Time Frame: Week 4
|
Number of Participants Who Responded According to Clinician Administered PTSD Scale Total Score
|
Week 4
|
Change in Depression: Beck Depression Inventory
Time Frame: Baseline, Week 4
|
Scale Range: 0-63; higher scores indicate greater symptom severity
|
Baseline, Week 4
|
Change in General Anxiety: Spielberger State-Trait Anxiety Inventory
Time Frame: Baseline, Week 4
|
Range: 20-80; higher scores indicate greater symptom severity
|
Baseline, Week 4
|
Change in Functional Impairment; Sheehan Disability Scale
Time Frame: Baseline, Week 4
|
Range: 0-30; greater values indicate greater disability severity ratings
|
Baseline, Week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jessica A Bomyea, M.S., San Diego State University/University of California, San Diego
- Principal Investigator: Ariel J Lang, Ph.D., University of California, San Diego
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
May 12, 2014
First Submitted That Met QC Criteria
May 13, 2014
First Posted (Estimate)
May 15, 2014
Study Record Updates
Last Update Posted (Actual)
November 6, 2017
Last Update Submitted That Met QC Criteria
October 4, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F31MH088170 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
-
Yale UniversityNational Center for PTSDCompletedPosttraumatic Stress Disorder (PTSD)United States
Clinical Trials on Computerized Cognitive Training - active
-
Salvador Sarró, MDInstituto de Salud Carlos III; Centro de Investigación Biomédica en Red de... and other collaboratorsCompleted
-
Sorlandet Hospital HFOslo University Hospital; University of Maryland; St. Olavs Hospital; Barrow Neurological... and other collaboratorsRecruitingMild Cognitive ImpairmentNorway
-
Lovisenberg Diakonale HospitalUniversity of Oslo; Yale UniversityUnknown
-
Sheba Medical CenterMaccabi Healthcare Services, IsraelCompleted
-
Posit Science CorporationCompletedInsomnia ChronicUnited States
-
Johns Hopkins UniversityYbrain Inc.Enrolling by invitationDementia | Mild Cognitive Impairment | Primary Progressive AphasiaUnited States
-
Hadassah Medical OrganizationCompletedAttention Deficit Hyperactivity DisorderIsrael
-
Michigan State UniversityUniversity of Michigan; Global Health Uganda LTDCompleted
-
University of MichiganCompletedSchizophrenia | Bipolar Disorder | Schizo Affective DisorderUnited States
-
University of BernRecruitingDementia | Alzheimer Disease | Mild Cognitive ImpairmentSwitzerland